These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 16716395)
1. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures. Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395 [TBL] [Abstract][Full Text] [Related]
2. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. Costantino L; Gandolfi F; Tosi G; Rivasi F; Vandelli MA; Forni F J Control Release; 2005 Nov; 108(1):84-96. PubMed ID: 16154222 [TBL] [Abstract][Full Text] [Related]
3. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. Tosi G; Costantino L; Rivasi F; Ruozi B; Leo E; Vergoni AV; Tacchi R; Bertolini A; Vandelli MA; Forni F J Control Release; 2007 Sep; 122(1):1-9. PubMed ID: 17651855 [TBL] [Abstract][Full Text] [Related]
4. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Mainardes RM; Evangelista RC Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139 [TBL] [Abstract][Full Text] [Related]
6. Single-step process to produce surface-functionalized polymeric nanoparticles. Sussman EM; Clarke MB; Shastri VP Langmuir; 2007 Nov; 23(24):12275-9. PubMed ID: 17963413 [TBL] [Abstract][Full Text] [Related]
7. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055 [TBL] [Abstract][Full Text] [Related]
8. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Dillen K; Weyenberg W; Vandervoort J; Ludwig A Eur J Pharm Biopharm; 2004 Nov; 58(3):539-49. PubMed ID: 15451528 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
11. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
12. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700 [TBL] [Abstract][Full Text] [Related]
13. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers. Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965 [TBL] [Abstract][Full Text] [Related]
15. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. Sant S; Poulin S; Hildgen P J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249 [TBL] [Abstract][Full Text] [Related]
16. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour. Unger F; Wittmar M; Morell F; Kissel T Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641 [TBL] [Abstract][Full Text] [Related]
17. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization. Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618 [TBL] [Abstract][Full Text] [Related]
18. Microporous structure and drug release kinetics of polymeric nanoparticles. Sant S; Thommes M; Hildgen P Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222 [TBL] [Abstract][Full Text] [Related]
19. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid). Kuo YC; Yu HW Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932 [TBL] [Abstract][Full Text] [Related]
20. PEG-PLA block copolymer as potential drug carrier: preparation and characterization. Ben-Shabat S; Kumar N; Domb AJ Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]